Back to search

University of Crete (UOC)

Μοριακή ανίχνευση και προγνωστική σημασία της ανάλυσης πολλαπλών δεικτών μικρομεταστατικής νόσου ( CK19, Mammaglobin-A, HER2) στο αίμα ασθενών με χειρουργήσιμο καρκίνο του μαστού

Abstract

dc:description

Purpose: To investigate the prognostic value of the molecular detection of Circulating Tumor Cells (CTCs) using 3 markers [Cytokeratin(CK) 19, Mammaglobin A (MGB1) and HER2] in early breast cancer. Experimental design: CK19mRNA+, MGB1mRNA+, and HER2mRNA+ cells, were detected using real-time (CK19) and nested (MGB1 and HER2) RT-PCR, in the peripheral blood of 175 women with stage I-III breast cancer before the initiation of adjuvant chemotherapy. CTCs’ detection was correlated with clinical outcome. In 10 patients, immunofluoresence staining experiments were performed to investigate the co-expression of CK, MGB1 and HER2 in CTCs. Results: CK19mRNA+, MGB1mRNA+ and HER2mRNA+ cells were detected in 41.1%, 8% and 28.6% of the 175 patients, respectively. Patients had one of the following molecular profiles: CK19mRNA+/MGB1mRNA+/HER2mRNA+ (n=8), CK19mRNA+/MGB1mRNA+/HER2mRNA- (n=1), CK19mRNA+/MGB1mRNA- /HER2mRNA+ (n=42), CK19mRNA+/MGB1mRNA-/HER2mRNA- (n=21), CK19mRNA-/MGB1mRNA+/HER2mRNA- (n=5), CK19mRNA-/MGB1mRNA- /HER2mRNA- (n=98). Double immunofluoresence experiments confirmed the following CTC phenotypes: CK+/MGB1+, CK+/MGB1-, CK-/MGB1+, CK+/HER2+, CK+/HER2-, MGB1+/HER2- and MGB1+/HER2+. In univariate analysis, the detection of CK19mRNA+, MGB1mRNA+ and HER2mRNA+ cells was associated with shorter disease-free survival (DFS), (p<0.001, p=0.001 and p<0.001, respectively), whereas the detection of CK19mRNA+ and MGB1mRNA+ cells was associated with worse overall survival (p=0.044 and p=0.034, respectively). In multivariate analysis, estrogen receptor-negative tumors and the detection of CK19mRNA+ and MGB1mRNA+ cells were independently associated with worse DFS. Conclusion: The detection of peripheral blood CK19mRNA+ and MGB1mRNA+ cells before adjuvant chemotherapy predicts poor DFS in women with early breast cancer.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ignatiadis, Michail
  • Ιγνατιάδης, Μιχαήλ

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24974

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ignatiadis, Michail; Ιγνατιάδης, Μιχαήλ. Μοριακή ανίχνευση και προγνωστική σημασία της ανάλυσης πολλαπλών δεικτών μικρομεταστατικής νόσου ( CK19, Mammaglobin-A, HER2) στο αίμα ασθενών με χειρουργήσιμο καρκίνο του μαστού. University of Crete (UOC), 2008. http://hdl.handle.net/10442/hedi/24974